- Home
- CELC vs TENB Comparison
CELC vs TENB Comparison
Compare CELC & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CELC | TENB |
|---|---|---|
| Founded | 2011 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.5B |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CELC | TENB |
|---|---|---|
| Price | $102.35 | $24.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 17 |
| Target Price | ★ $100.13 | $39.25 |
| AVG Volume (30 Days) | 959.5K | ★ 1.1M |
| Earning Date | 11-12-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $974,603,000.00 |
| Revenue This Year | N/A | $12.22 |
| Revenue Next Year | N/A | $7.62 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 11.05 |
| 52 Week Low | $7.58 | $25.28 |
| 52 Week High | $112.64 | $45.45 |
Technical Indicators
Market Signals| Indicator | CELC | TENB |
|---|---|---|
| Relative Strength Index (RSI) | 64.23 | 31.11 |
| Support Level | $100.00 | $26.11 |
| Resistance Level | $112.64 | $27.24 |
| Average True Range (ATR) | 5.11 | 0.62 |
| MACD | -0.99 | 0.03 |
| Stochastic Oscillator | 38.05 | 13.27 |
Price Performance
Historical ComparisonAbout CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About TENB Tenable Holdings Inc.
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.